Com-guard.com, Inc. (GUD)
0.00
0.00 (0.00%)
Latest Headlines
Knight Announces Early Warning Filing Regarding Shares of Crescita
June 5, 2026 6:00 PM - Globe NewsWire
Knight to Present at the Jefferies 2026 Healthcare Conference in New York City
May 28, 2026 7:30 AM - Globe NewsWire
Knight Therapeutics Announces Launch of TAVALISSE® in Mexico
May 27, 2026 6:00 PM - Globe NewsWire
Knight to Present at the 2026 RBC Capital Markets Global Healthcare Conference in New York City
May 12, 2026 6:30 AM - Globe NewsWire
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
May 8, 2026 6:30 AM - Globe NewsWire
Knight Therapeutics Reports First Quarter 2026 Results
May 7, 2026 6:30 AM - Globe NewsWire
Knight Therapeutics Inc. announces voting results from the Annual General Meeting
May 6, 2026 4:48 PM - Globe NewsWire
Notice of Knight Therapeutics' First Quarter 2026 Results Conference Call
April 30, 2026 7:31 AM - Globe NewsWire
Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 15, 2026 7:31 AM - Globe NewsWire
Knight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
March 27, 2026 12:27 PM - Globe NewsWire
Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results
March 19, 2026 7:31 AM - Globe NewsWire
Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
March 17, 2026 7:31 AM - Globe NewsWire
Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico
March 17, 2026 7:31 AM - Globe NewsWire
Notice of Knight Therapeutics' Fourth Quarter and Year End 2025 Results Conference Call
March 12, 2026 7:31 AM - Globe NewsWire
Full Article List
